MEDVF OTC
Medivolve Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -95.0%
1Y: -95.0%
3Y: -99.7%
5Y: +575.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
-147.9% ▼
Capital Expenditures
$239K
+0.0% ▲
5Y CAGR: +26.1%
Free Cash Flow
-$3M
-151.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3M
-183.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$38M | -$7M | -$18M | -$17M |
| Depreciation & Amort. | $0 | $3M | $5M | $2M | $400K |
| Stock-Based Comp. | $157K | $2M | $3M | $18K | $112K |
| Change in Working Capital | -$149K | $2M | -$24M | $12M | $2M |
| Other Non-Cash Items | -$2M | $5M | -$123K | $3M | $12M |
| Operating Cash Flow | -$4M | -$11M | -$9M | $6M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$4M | -$43K | $0 | -$239K |
| Acquisitions (Net) | $0 | $43K | -$165K | $0 | -$239K |
| Investment Purchases | -$918K | -$3M | -$418K | $0 | $0 |
| Investment Sales | $0 | $680K | $418K | $0 | $0 |
| Other Investing | $0 | $487K | -$418K | $0 | $239K |
| Investing Cash Flow | -$918K | -$5M | -$626K | $0 | -$239K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $9M | $1M | -$1M | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$166K | $308K | -$796K | -$1M |
| Financing Cash Flow | $0 | $14M | $8M | -$2M | -$332K |
| Net Change in Cash | -$4M | $850K | -$739K | $4M | -$3M |
| Cash End of Period | $976 | $851K | $112K | $4M | $806K |
| Free Cash Flow | -$4M | -$15M | -$9M | $6M | -$3M |